Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002156955 | SCV002332856 | benign | not provided | 2024-01-20 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002156955 | SCV004133286 | benign | not provided | 2022-10-01 | criteria provided, single submitter | clinical testing | EXPH5: BP4, BS1, BS2 |
Breakthrough Genomics, |
RCV002156955 | SCV005229347 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003978503 | SCV004791835 | likely benign | EXPH5-related disorder | 2024-01-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |